3-[6-(Aminomethyl)pyridin-2-yl]-1,3-oxazinan-2-one dihydrochloride, 1g

2-(1-Methyl-1H-indol-3-yl)acetamide, 95.0%, 1g

3-allyl-5,7-dimethylbenzo[d]thiazol-2(3H)-imine hydrobromide, 95.0%, 1g

Tetrakis(4-aminophenyl)methane>95.0%(HPLC)(T)1g

Butanedioic acid, compd. with 7-cyclopentyl-N,N-dimethyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide (1:1), 98%, 5g

2-((2,5-Dimethoxyphenyl)amino)ethan-1-ol, 97%, 1g

3-(3-chloro-1H-1,2,4-triazol-5-yl)-1-propanol hydrochloride hydrate, 95.0%, 5g

(2-Bromo-3-butoxy-6-fluorophenyl)boronic acid, 95.0%, 5g

tert-Butyl (4-bromo-3-cyano-7-fluorobenzo[b]thiophen-2-yl)carbamate, 98%, 10g

(E)-5-((4-((2-Carboxyethyl)carbamoyl)phenyl)diazenyl)-2-hydroxybenzoic acid, 95+%, 50mg

TERT-BUTYL 3-AMINO-3-(2-ETHOXY-2-OXOETHYL)AZETIDINE-1-CARBOXYLATE, 95.0%, 500mg

phenyl[4-(2-phenylethyl)phenyl]methanone, 95.0%, 1g

2,4-Bis(trifluoromethyl)benzyl alcohol, 98.0%, 25g